Elevation Wealth Partners
TNDM icon

Elevation Wealth Partners’s Tandem Diabetes Care TNDM Stock Holding History

Elevation Wealth Partners’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-60
Closed -$906 – 1405
2026
Q2 		$906 Buy
60
+46
+329% +$803 ﹤0.01% 1264
2026
Q1 		$269 Buy
+14
New +$304 ﹤0.01% 1058

Other funds holding TNDM

Paradice Investment Management
Paradice Investment Management Denver, Colorado $594M AUM 28.38% 1-Year Est. Return
Fideuram Asset Management (Ireland)
Fideuram Asset Management (Ireland) Dublin 1 $4.57B AUM 30.36% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Oppenheimer Asset Management
Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return
Fideuram - Intesa Sanpaolo Private Banking
Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Elevation Wealth Partners's TNDM Position: Q3 2026 in Review

Elevation Wealth Partners sold out of Tandem Diabetes Care (TNDM) in Q3 2026, closing a stake of 60 shares — an estimated $906 sold.

Elevation Wealth Partners first reported a position in TNDM in Q1 2026 and held it in 2 quarters. The position peaked at $906 in Q2 2026. 57 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.

  • Elevation Wealth Partners reported no remaining Tandem Diabetes Care position as of Q3 2026 after selling out during the quarter.
  • Elevation Wealth Partners sold 60 Tandem Diabetes Care shares in Q3 2026, an estimated $906.
  • Elevation Wealth Partners first reported a position in Tandem Diabetes Care in Q1 2026 and held it in 2 quarters.
  • Elevation Wealth Partners's Tandem Diabetes Care position peaked at $906 in Q2 2026.
  • 57 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.